Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02RMR
|
||||
| Former ID |
DNC011866
|
||||
| Drug Name |
1,3-Diethyl-3,7-dihydro-purine-2,6-dione
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [533429] | ||
| Formula |
C9H12N4O2
|
||||
| Canonical SMILES |
CCN1C2=C(C(=O)N(C1=O)CC)NC=N2
|
||||
| InChI |
1S/C9H12N4O2/c1-3-12-7-6(10-5-11-7)8(14)13(4-2)9(12)15/h5H,3-4H2,1-2H3,(H,10,11)
|
||||
| InChIKey |
GIMNFISWKTZFKJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A1 receptor | Target Info | Inhibitor | [533429] | |
| Adenosine A2b receptor | Target Info | Inhibitor | [533429] | ||
| Adenosine A2a receptor | Target Info | Inhibitor | [533429] | ||
| KEGG Pathway | cGMP-PKG signaling pathway | ||||
| cAMP signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Morphine addictionhsa04015:Rap1 signaling pathway | |||||
| Calcium signaling pathway | |||||
| Vascular smooth muscle contraction | |||||
| Alcoholismhsa04015:Rap1 signaling pathway | |||||
| Parkinson's disease | |||||
| Alcoholism | |||||
| Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.